About

Dr. Pedro F. Escobar is a pioneering figure in gynecologic oncology and minimally invasive surgery, whose work has fundamentally reshaped surgical approaches to cancer care. His primary research focuses on advancing laparoendoscopic single-site surgery (LESS) and robotic-assisted techniques to reduce patient trauma and improve outcomes. Dr. Escobar’s landmark 2009 paper, “Laparoendoscopic single-site surgery (LESS) in gynecologic oncology,” with 313 citations, introduced a paradigm-shifting technique that minimized incisions while maintaining oncologic precision. He further revolutionized the field by leading the first human surgery using the da Vinci Single-Site platform for cholecystectomy (193 citations), demonstrating the feasibility of single-port robotic systems. His contributions extend to comparative effectiveness, as shown in a multi-site study of high-grade endometrial cancer (109 citations), which validated minimally invasive approaches over traditional laparotomy. With over 1,400 total citations across his most-cited works, Dr. Escobar has not only advanced surgical technology but also provided critical evidence for its adoption. His systematic review on robotic surgery in gynecology (103 citations) remains a foundational resource. Through these achievements, Dr. Escobar has established himself as a leader in making complex gynecologic surgeries safer, less invasive, and more accessible.

Research Focus

Key Achievements

20
H-Index
29
Papers
1,894
Total Citations
65
Avg Citations/Paper
🏆 Most Cited Paper
Laparoendoscopic single-site surgery (LESS) in gynecologic oncology: Technique and initial report
313 citations · 2009
📈 Most Prolific Year: 2011 (8 Papers)
🤝 Key Collaborators: 87
🏛 Institutions: Cleveland Clinic, The University of Texas MD Anderson Cancer Center, Hospital Oncológico Andrés Grillasca, Cleveland Clinic Lerner College of Medicine, Ponce Health Sciences University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago